(19)
(11) EP 3 694 512 A1

(12)

(43) Date of publication:
19.08.2020 Bulletin 2020/34

(21) Application number: 17788070.5

(22) Date of filing: 12.10.2017
(51) International Patent Classification (IPC): 
A61K 31/454(2006.01)
A61K 31/7056(2006.01)
A61P 31/12(2006.01)
A61K 31/498(2006.01)
A61K 31/7072(2006.01)
(86) International application number:
PCT/US2017/056298
(87) International publication number:
WO 2019/074507 (18.04.2019 Gazette 2019/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(71) Applicant: Abbvie Inc.
North Chicago, IL 60064 (US)

(72) Inventors:
  • AWNI, Walid M.
    Green Oaks, Illinois 60048 (US)
  • BERNSTEIN, Barry M.
    Mequon, Wisconsin 53092 (US)
  • CAMPBELL, Andrew L.
    Lake Forest, Illinois 60045 (US)
  • DUTTA, Sandeep
    Lincolnshire, Illinois 60069 (US)
  • LIN, Chih-Wei
    Vernon Hills, Illinois 60061 (US)
  • LIU, Wei
    Mundelein, Illinois 60060 (US)
  • PILOT-MATIAS, Tami
    Green Oaks, Illinois 60048 (US)
  • MENON, Rajeev M.
    Buffalo Grove, Illinois 60089 (US)
  • MENSING, Sven
    68001 Mannheim (DE)
  • PODSADECKI, Thomas J.
    Chicago, Illinois 60654 (US)
  • RODRIGUES JUNIOR, Lino
    Chicago, Illinois 60660 (US)
  • SAMANTI, Suvajit
    North Chicago, Illinois 60064 (US)
  • TRINH, Roger
    Chicago, Illinois 60640 (US)
  • WANG, Tianli
    Lake Bluff, Illinois 60044 (US)
  • YAO, Betty B.
    Libertyville, Illinois 60048 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) METHODS FOR TREATING HCV